Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
37.25
+2.25 (6.43%)
At close: Jan 23, 2026
Genus Market Cap
Genus has a market cap or net worth of $2.81 billion as of February 12, 2026. Its market cap has increased by 81.03% in one year.
Market Cap
2.81B
Enterprise Value
3.10B
Revenue
921.77M
Ranking
n/a
PE Ratio
106.17
Stock Price
$37.25
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 50.66M to 2.81B, an increase of 5,441.93%. That is a compound annual growth rate of 15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.81B | 20.13% |
| Dec 31, 2025 | 2.34B | 83.34% |
| Dec 31, 2024 | 1.27B | -29.66% |
| Dec 29, 2023 | 1.81B | -22.93% |
| Dec 30, 2022 | 2.35B | -46.03% |
| Dec 31, 2021 | 4.36B | 17.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |